Rockefeller Capital Management L.P. Grows Position in Centene Corporation $CNC

Market Beat
2025.11.27 10:35
portai
I'm PortAI, I can summarize articles.

Rockefeller Capital Management L.P. increased its holdings in Centene Corporation by 71% in Q2, owning 22,903 shares valued at $1,243,000. Other institutional investors also adjusted their positions in Centene. The company's stock opened at $39.72, with a market cap of $19.52 billion. Analysts have mixed ratings on Centene, with a consensus price target of $40.00.

Rockefeller Capital Management L.P. lifted its holdings in Centene Corporation (NYSE:CNC - Free Report) by 71.0% in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 22,903 shares of the company's stock after purchasing an additional 9,506 shares during the quarter. Rockefeller Capital Management L.P.'s holdings in Centene were worth $1,243,000 at the end of the most recent quarter.

  • MarketBeat Week in Review – 07/07 - 07/11

Other hedge funds also recently bought and sold shares of the company. Geode Capital Management LLC increased its holdings in shares of Centene by 2.2% in the 2nd quarter. Geode Capital Management LLC now owns 13,208,639 shares of the company's stock worth $718,547,000 after buying an additional 279,637 shares during the last quarter. Invesco Ltd. grew its position in Centene by 5.1% in the first quarter. Invesco Ltd. now owns 11,091,964 shares of the company's stock worth $673,393,000 after acquiring an additional 536,508 shares in the last quarter. AQR Capital Management LLC increased its stake in Centene by 42.7% during the first quarter. AQR Capital Management LLC now owns 11,049,494 shares of the company's stock worth $669,820,000 after acquiring an additional 3,306,796 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in shares of Centene by 3.1% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 4,810,489 shares of the company's stock valued at $292,045,000 after purchasing an additional 143,573 shares during the last quarter. Finally, Dimensional Fund Advisors LP boosted its holdings in shares of Centene by 0.6% in the 1st quarter. Dimensional Fund Advisors LP now owns 4,433,451 shares of the company's stock worth $269,134,000 after purchasing an additional 28,462 shares during the period. Hedge funds and other institutional investors own 93.63% of the company's stock.

Centene Stock Performance

Shares of NYSE:CNC opened at $39.72 on Wednesday. The firm's 50 day simple moving average is $35.70 and its 200-day simple moving average is $38.57. The company has a debt-to-equity ratio of 0.83, a quick ratio of 1.10 and a current ratio of 1.08. Centene Corporation has a one year low of $25.08 and a one year high of $66.81. The firm has a market cap of $19.52 billion, a PE ratio of -3.67, a price-to-earnings-growth ratio of 1.24 and a beta of 0.49.

  • Why Centene Stock Dropped 40% — And Whether It's a Buy Now

Centene (NYSE:CNC - Get Free Report) last announced its quarterly earnings data on Wednesday, October 29th. The company reported $0.50 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.21) by $0.71. The company had revenue of $49.69 billion for the quarter, compared to analysts' expectations of $47.50 billion. Centene had a positive return on equity of 7.82% and a negative net margin of 2.85%.Centene's revenue was up 18.2% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.62 earnings per share. As a group, equities analysts predict that Centene Corporation will post 6.86 EPS for the current year.

Analyst Upgrades and Downgrades

CNC has been the subject of a number of analyst reports. Mizuho raised their price target on Centene from $28.00 to $40.00 and gave the stock a "neutral" rating in a research report on Thursday, October 9th. Zacks Research raised shares of Centene from a "strong sell" rating to a "hold" rating in a research note on Wednesday, October 29th. JPMorgan Chase & Co. increased their price objective on shares of Centene from $30.00 to $38.00 and gave the stock a "neutral" rating in a research report on Tuesday, November 4th. Morgan Stanley boosted their target price on Centene from $28.00 to $38.00 and gave the company an "equal weight" rating in a research report on Tuesday, October 14th. Finally, Truist Financial reiterated a "buy" rating and issued a $45.00 price target (up from $42.00) on shares of Centene in a report on Thursday, October 30th. Three investment analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus price target of $40.00.

  • Top Analyst-Rated Healthcare Stocks to Watch Now

Check Out Our Latest Stock Report on CNC

Centene Profile

(Free Report)

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.

Featured Articles

  • Five stocks we like better than Centene
  • What Are Dividend Challengers?
  • Warner Bros. Sale Rumors Heat Up: What Investors Need to Know
  • What Makes a Stock a Good Dividend Stock?
  • From Science Project to Solvent: WeRide’s 761% Revenue Surge
  • Stock Trading Terms - Stock Terms Every Investor Needs to Know
  • Will the S&P 500 Rally in December? These 3 Signals Point to a Big Move Ahead

Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Corporation (NYSE:CNC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Centene Right Now?

Before you consider Centene, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Centene wasn't on the list.

While Centene currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here